跳至主要内容
临床试验/IRCT201508064226N3
IRCT201508064226N3已完成未知

The effect of vitamin B12 supplementation to the standard therapeutic regimen on sustained viral response in genotype 1 chronic HCV infection

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Exclusion criteria: age <18 or>70 year, previous treatment with interferon and ribavirin, concomitant causes of liver disease, such as hepatitis B virus infection, autoimmunity and alcohol abuse (>40 g/day for men and >20 g/day for women),
  • HIV infection, hepatocellular carcinoma, decompensated cirrhosis, severe concurrent disease, contraindications to treatment.
  • age between 18 to70 years, Lack of concomitant causes of liver disease, such as hepatitis B virus infection, autoimmunity and alcohol abuse (>40 g/day for men and >20 g/day for women), Lack of HIV infection, Lack of hepatocellular carcinoma, Lack of decompensated cirrhosis, Lack of severe concurrent disease.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验